Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides

Microbes and Infection

Volumn 13, Issue 8-9, 2011, Pages 761-765

  Rieg, Siegbert ^a   Kaasch, Achim J ^b   Wehrle, Julian ^a   Hofmann, Silke C ^a   Szymaniak Vits, Magdalena ^a   Saborowski, Viola ^a   Jonas, Daniel ^a   Kalbacher, Hubert ^c   Seifert, Harald ^b   Kern, Winfried V ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antimicrobial peptides; Innate immunity; INSTINCT; Staphylococcus aureus

Indexed keywords

BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; INDOLICIDIN;

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BROTH DILUTION; COLONY FORMING UNIT; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; INFECTION SENSITIVITY; INNATE IMMUNITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTEREMIA; CATTLE; COLONY COUNT, MICROBIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

BOVINAE; STAPHYLOCOCCUS AUREUS;

EID: 79959906068     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.03.010     Document Type: Article

References (15)

1. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
2. van Belkum A. Staphylococcal colonization and infection: homeostasis versus disbalance of human (innate) immunity and bacterial virulence. Curr. Opin. Infect. Dis. 2006, 19:339-344.
3. Lai Y., Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30:131-141.
4. Peschel A., Sahl H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4:529-536.
5. Rieg S., Peyerl-Hoffmann G., de With K., Theilacker C., Wagner D., Hübner J., Dettenkofer M., Kaasch A., Seifert H., Kern W.V. Mortality of S. aureus bacteremia and infectious diseases specialist consultation-a study of 521 patients in Germany. J. Infect. 2009, 59:232-239.
6. Weidenmaier C., Kokai-Kun J.F., Kristian S.A., Chanturiya T., Kalbacher H., Gross M., Nicholson G., Neumeister B., Mond J.J., Peschel A. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 2004, 10:243-245.
7. Steinberg D.A., Lehrer R.I. Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. Methods Mol. Biol. 1997, 78:169-186.
8. Chromek M., Slamova Z., Bergman P., Kovács L., Podracká L., Ehrén I., Hökfelt T., Gudmundsson G.H., Gallo R.L., Agerberth B., Brauner A. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 2006, 12:636-641.
9. Ouhara K., Komatsuzawa H., Kawai T., Nishi H., Fujiwara T., Fujiue Y., Kuwabara M., Sayama K., Hashimoto K., Sugai M. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J. Antimicrob. Chemother. 2008, 61:1266-1269.
10. Midorikawa K., Ouhara K., Komatsuzawa H., Kawai T., Yamada S., Fujiwara T., Yamazaki K., Sayama K., Taubman M.A., Kurihara H., Hashimoto K., Sugai M. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 2003, 71:3730-3739.
11. Gottlieb C.T., Thomsen L.E., Ingmer H., Mygind P.H., Kristensen H.H., Gram L. Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression. BMC Microbiol. 2008, 8:205.
12. Kupferwasser L.I., Yeaman M.R., Shapiro S.M., Nast C.C., Bayer A.S. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 2002, 105:746-752.
13. Fowler V.G., Sakoulas G., McIntyre L.M., Meka V.G., Arbeit R.D., Cabell C.H., Stryjewski M.E., Eliopoulos G.M., Reller L.B., Corey G.R., Jones T., Lucindo N., Yeaman M.R., Bayer A.S. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 2004, 190:1140-1149.
14. Rieg S., Steffen H., Seeber S., Humeny A., Kalbacher H., Dietz K., Garbe C., Schittek B. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J. Immunol. 2005, 174:8003-8010.
15. Zanger P., Holzer J., Schleucher R., Steffen H., Schittek B., Gabrysch S. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J. Infect. Dis. 2009, 200:1907-1915.